Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-514004-14-00

Acronym

NIO752B12201

Enrollment

Registered

2024-08-02

Start date

2023-02-23

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s Disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

Finland, France, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026